C2ORF3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.117600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.522600E-01
Normal-vs-Stage2
1.393350E-01
Normal-vs-Stage3
4.689700E-02
Normal-vs-Stage4
9.609600E-01
Stage1-vs-Stage2
1.518400E-01
Stage1-vs-Stage3
7.316200E-02
Stage1-vs-Stage4
6.164600E-01
Stage2-vs-Stage3
3.627800E-01
Stage2-vs-Stage4
1.195970E-03
Stage3-vs-Stage4
1.019530E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.567200E-01
Normal-vs-AfricanAmerican
3.079200E-01
Normal-vs-Asian
1.239900E-02
Caucasian-vs-AfricanAmerican
8.615200E-01
Caucasian-vs-Asian
3.198100E-02
AfricanAmerican-vs-Asian
4.841700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.812160E-01
Normal-vs-Female
2.759600E-01
Male-vs-Female
3.035800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.702400E-01
Normal-vs-Age(41-60Yrs)
2.252400E-01
Normal-vs-Age(61-80Yrs)
1.996400E-01
Normal-vs-Age(81-100Yrs)
2.501600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.382610E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.204250E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.103000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.224600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.423200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.827200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.351640E-01
Normal-vs-Daily Drinker
9.606200E-02
Normal-vs-Weekly Drinker
1.800180E-01
Normal-vs-Occasional Drinker
8.416400E-02
Normal-vs-Social Drinker
4.020800E-01
Non Drinker-vs-Daily Drinker
5.795400E-01
Non Drinker-vs-Weekly Drinker
7.251200E-01
Non Drinker-vs-Occasional Drinker
7.772200E-01
Non Drinker-vs-Social Drinker
4.971600E-01
Daily Drinker-vs-Weekly Drinker
9.238200E-01
Daily Drinker-vs-Occasional Drinker
4.136000E-01
Daily Drinker-vs-Social Drinker
3.017600E-01
Weekly Drinker-vs-Occasional Drinker
5.879000E-01
Weekly Drinker-vs-Social Drinker
4.409600E-01
Occasional Drinker-vs-Social Drinker
6.667400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.873590E-02
Normal-vs-Grade 2
5.564900E-03
Normal-vs-Grade 3
9.399600E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.603800E-01
Grade 1-vs-Grade 3
8.966600E-01
Grade 1-vs-Grade 4
1.873590E-02
Grade 2-vs-Grade 3
8.532200E-01
Grade 2-vs-Grade 4
5.564900E-03
Grade 3-vs-Grade 4
9.399600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.109150E-01
Normal-vs-NonDiabetic
1.408960E-01
Diabetic-vs-NonDiabetic
6.302400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.766340E-02
Normal-vs-NoPancreatitis
1.649420E-01
Pancreatitis-vs-NoPancreatitis
2.328800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.586400E-01
Normal-vs-N1
1.505590E-01
N0-vs-N1
2.896800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.984800E-01
Normal-vs-TP53-NonMutant
6.795600E-01
TP53-Mutant-vs-TP53-NonMutant
6.278200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
